-+ 0.00%
-+ 0.00%
-+ 0.00%

Global UAV signs LOI to acquire Nexus Peptide Sciences, plans $3 million-$5 million equity raise

PUBT·07/27/2026 14:23:07
Listen to the news
Global UAV signs LOI to acquire Nexus Peptide Sciences, plans $3 million-$5 million equity raise
  • Global UAV Technologies entered a July 27, 2026 LOI to acquire Vancouver-based biotech Nexus Peptide Sciences.
  • Consideration includes 20,300,000 common shares, 7,000,000 transferable warrants exercisable at $0.10, plus a $100,000 cash finder’s fee.
  • Each warrant converts into one share at $0.10 for two years following closing.
  • The buyer targets an equity financing of $3 million to $5 million on or before closing.
  • Parties aim to sign a definitive agreement by Aug. 31, 2026; Nexus would become a wholly owned subsidiary at closing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global UAV Technologies Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607271022NEWSFILECNPR____20260727_306632_1) on July 27, 2026, and is solely responsible for the information contained therein.